[BioTimes] PDRN (Polydeoxyribonucleotide), which is attracting attention as a key ingredient for skin regeneration and tissue repair, is a high-functional active ingredient that has rapidly established itself in medical and dermatological treatment fields. In this trend, 'PYDERIN', a specialized brand for high-purity low-molecular PDRN, has been steadily building trust in the market exclusively for hospitals and clinics, and has been solidifying its field-oriented position by introducing high-precision solutions tailored to medical standards, it announced on the 7th.
The PDRN products provided by PYDERIN are composed of a low-molecular specification with 99% purity and a molecular weight of 97kDa, making them excellent in promoting cell regeneration and aiding rapid recovery of damaged skin. High-purity low-molecular DNA has a higher absorption rate and easier tissue penetration compared to existing high-molecular components, making it particularly preferred by professionals who want to maximize treatment effects.
All PYDERIN products are developed based on pharmaceutical-level raw materials and purification standards, and only high-quality grades of medical salmon-derived DNA are selected as raw materials. This enhances the predictability of skin reactions after treatment and strengthens safety so that it can be used with confidence even for sensitive patient groups.
Currently, PYDERIN is focusing on PDRN solutions for treatment assistance and recovery management used in dermatology, plastic surgery, and aesthetic medical centers, rather than simple functional cosmetics. The product lineup, consisting of ampoules, intensive care agents, and multi-repair solutions, is designed to be flexibly applied to various pre- and post-treatment protocols, and its efficacy and stability are consistently proven by field experts.
A PYDERIN official introduced, "PYDERIN is a brand designed to meet the needs and standards of the medical field rather than general consumers from the early stages of its launch," and added, "As it has undergone rigorous verification by medical institutions, we have focused on field-customized performance and results-oriented prescriptions." He further stated, "We will continue to expand the depth and breadth of professional PDRN solutions while maintaining the brand's identity without wavering."
Meanwhile, PYDERIN is currently distributed mainly in major domestic hospitals and clinics, and is also gaining traction in some overseas medical markets. It plans to establish itself as a choice for professionals who want 'real effects' by continuing sustainable product development based on medical standards, without being swayed by short-term trends.
[BioTimes = Reporter Choi Jin-ju] news@biotimes.co.kr
Source: BioTimes (http://www.biotimes.co.kr)
